Summary of Increased oHSV Replication in Cancer Cell Lines Pre-treated with HDAC Inhibitors.
收藏数据链接：
官方服务：
资源简介：
No increase (-) or increases in replication of >2 fold (+), >5 fold (++) and >10 fold (+++) are shown.1For breast cancer.2Clinically approved for the treatment of cutaneous T cell lymphoma.3Also inhibits the Class IIa enzyme HDAC 9.
创建时间：
2015-12-02
